We report (i) the prevalence of systemic iron release in patients with CAD, (ii) the rate of correlation of hepcidin and sTfR with various clinical and demographic factors, and (iii), its prognostic value in 811 patients with CAD beyond established and emerging cardiovascular risk factors. The gene discussed is TFRC; the disease is coronary artery disorder.